. . "50"^^ . . . . . . "2022-05-31T00:00:00Z"^^ . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . . "clinical trial"@en . . . . . . "90"^^ . . . . "Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease"@nl . . "Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease"@nl . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "klinisch onderzoek"@nl . "Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)"@en . . . . . . . . . . . . . . . . . . . . . . "Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)"@en . . . . . . "Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)"@en . . . . . . . . . . "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease"@en . . "Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease"@nl . "2018-06-06T00:00:00Z"^^ . . "760"^^ . . . "NCT03444870" . . . .